258 related articles for article (PubMed ID: 22348138)
1. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.
Otsuka N; Han HJ; Toyoizumi-Ajisaka H; Nakamura Y; Arakawa Y; Shibayama K; Kamachi K
PLoS One; 2012; 7(2):e31985. PubMed ID: 22348138
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
Pawloski LC; Queenan AM; Cassiday PK; Lynch AS; Harrison MJ; Shang W; Williams MM; Bowden KE; Burgos-Rivera B; Qin X; Messonnier N; Tondella ML
Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623
[TBL] [Abstract][Full Text] [Related]
3. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
[TBL] [Abstract][Full Text] [Related]
4. Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012.
Zeddeman A; van Gent M; Heuvelman CJ; van der Heide HG; Bart MJ; Advani A; Hallander HO; Wirsing von Konig CH; Riffelman M; Storsaeter J; Vestrheim DF; Dalby T; Krogfelt KA; Fry NK; Barkoff AM; Mertsola J; He Q; Mooi F
Euro Surveill; 2014 Aug; 19(33):. PubMed ID: 25166348
[TBL] [Abstract][Full Text] [Related]
5. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
[TBL] [Abstract][Full Text] [Related]
6. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
[TBL] [Abstract][Full Text] [Related]
7. Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.
Zomer A; Otsuka N; Hiramatsu Y; Kamachi K; Nishimura N; Ozaki T; Poolman J; Geurtsen J
Microb Genom; 2018 May; 4(5):. PubMed ID: 29771235
[TBL] [Abstract][Full Text] [Related]
8. Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007-2014.
Vodzak J; Queenan AM; Souder E; Evangelista AT; Long SS
Clin Infect Dis; 2017 Jan; 64(1):60-66. PubMed ID: 27624959
[TBL] [Abstract][Full Text] [Related]
9. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y
J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
[TBL] [Abstract][Full Text] [Related]
10. Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.
Tsang RS; Shuel M; Jamieson FB; Drews S; Hoang L; Horsman G; Lefebvre B; Desai S; St-Laurent M
Int J Infect Dis; 2014 Nov; 28():65-9. PubMed ID: 25244999
[TBL] [Abstract][Full Text] [Related]
11. Pertactin-deficient
Barkoff AM; Mertsola J; Pierard D; Dalby T; Hoegh SV; Guillot S; Stefanelli P; van Gent M; Berbers G; Vestrheim D; Greve-Isdahl M; Wehlin L; Ljungman M; Fry NK; Markey K; He Q
Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782265
[TBL] [Abstract][Full Text] [Related]
12. Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan.
Hiramatsu Y; Miyaji Y; Otsuka N; Arakawa Y; Shibayama K; Kamachi K
Emerg Infect Dis; 2017 Apr; 23(4):699-701. PubMed ID: 28322702
[TBL] [Abstract][Full Text] [Related]
13. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children.
Mastrantonio P; Spigaglia P; Oirschot HV; van der Heide HGJ; Heuvelman K; Stefanelli P; Mooi FR
Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2069-2075. PubMed ID: 10463173
[TBL] [Abstract][Full Text] [Related]
14. Naturally circulating pertactin-deficient
Kroes MM; Miranda-Bedate A; Hovingh ES; Jacobi R; Schot C; Pupo E; Raeven RHM; van der Ark AAJ; van Putten JPM; de Wit J; Mariman R; Pinelli E
Emerg Microbes Infect; 2021 Dec; 10(1):1358-1368. PubMed ID: 34132167
[TBL] [Abstract][Full Text] [Related]
15. The evolving nature of
Tsang RSW; Shuel M; Cronin K; Deng S; Whyte K; Marchand-Austin A; Ma J; Bolotin S; Crowcroft N; Schwartz K; Van Domselaar G; Graham M; Jamieson FB
Can J Microbiol; 2019 Nov; 65(11):823-830. PubMed ID: 31295416
[TBL] [Abstract][Full Text] [Related]
16. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
[TBL] [Abstract][Full Text] [Related]
17. Evolution of
Bouchez V; Guillot S; Landier A; Armatys N; Matczak S; ; Toubiana J; Brisse S
Euro Surveill; 2021 Sep; 26(37):. PubMed ID: 34533118
[TBL] [Abstract][Full Text] [Related]
18. Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018.
Mir-Cros A; Moreno-Mingorance A; Martín-Gómez MT; Abad R; Bloise I; Campins M; González-Praetorius A; Gutiérrez MN; Martín-González H; Muñoz-Almagro C; Orellana MÁ; de Pablos M; Roca-Grande J; Rodrigo C; Rodríguez ME; Uriona S; Vidal MJ; Pumarola T; Larrosa MN; González-López JJ
Emerg Infect Dis; 2022 May; 28(5):967-976. PubMed ID: 35447067
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variation of Bordetella pertussis in Austria.
Wagner B; Melzer H; Freymüller G; Stumvoll S; Rendi-Wagner P; Paulke-Korinek M; Repa A; Mooi FR; Kollaritsch H; Mittermayer H; Kessler HH; Stanek G; Steinborn R; Duchêne M; Wiedermann U
PLoS One; 2015; 10(7):e0132623. PubMed ID: 26182210
[TBL] [Abstract][Full Text] [Related]
20. Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor.
Hovingh ES; Mariman R; Solans L; Hijdra D; Hamstra HJ; Jongerius I; van Gent M; Mooi F; Locht C; Pinelli E
Emerg Microbes Infect; 2018 Mar; 7(1):39. PubMed ID: 29559630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
